About Paul Mansfield
20+ Years of Experience
Excellence in Research
Hyperthermic Intraperitoneal Chemotherapy
Board Certified in Surgery
Dr. Mansfield has expertise in the use of hyperthermic intraperitoneal chemotherapy – often referred to as HIPEC – in conjunction with cytoreductive surgery to treat peritoneal mesothelioma.
HIPEC involves circulating a heated chemotherapy solution through the abdominal cavity for up to 90 minutes to kill any microscopic tumor cells that evaded the surgeon.
The procedure allows for a higher dose of chemotherapy than standard systemic chemotherapy because it stays in the abdominal cavity, which decreases side effects.
It is the most effective mesothelioma treatment option for patients with the peritoneal type of the rare cancer.
In addition to mesothelioma, Mansfield also uses HIPEC to treat appendix cancer, soft tissue sarcomas, gastric cancer and gastroesophageal cancer.
More Than Two Decades at MD Anderson
Mansfield is a professor of Surgical Oncology and vice president of Acute Care Services at the University of Texas MD Anderson Cancer Center.
For almost 20 years, he served as the medical director of Infusion Therapy at the university. He also has served more than a decade as the head of Emergency Services.
He oversees almost a dozen studies involving various topics being explored at MD Anderson such as gastrointestinal surgeries, restaging low-grade appendiceal cancers and dissection techniques with melanoma.
In 2019, Mansfield co-authored a study published in the Annals of Surgical Oncology involving the safety of laparoscopic HIPEC for gastric cancer and the incidence of resulting gastrectomy.
Mansfield has authored or co-authored more than 140 articles in peer-reviewed publications during his career. He also is a regular presenter at national and international medical conferences.
Award Winner as a Teacher and Surgeon
Mansfield earned his medical degree at Thomas Jefferson University in Philadelphia before his residency in general surgery at the Hospital of the University of Pennsylvania.
He completed a fellowship in Surgical Oncology at MD Anderson and gained his full-time appointment to the department in 1991.
As a professor, Mansfield earned the Outstanding Teacher Award in 1994 and the Faculty Achievement Award for Patient Care in 2002. MD Anderson presented him with the Patients’ Choice Award in 2009.
In addition to his clinical responsibilities, he is a member of the Houston Hospice Board of Directors.
As a surgeon, he works closely with medical oncologists, pulmonologists and radiologists at MD Anderson to formulate a plan of personalized, multidisciplinary care for each patient.
Disclaimer: Dr. Paul Mansfield has no professional affiliation with Asbestos.com.
3 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
University of Texas MD Anderson Cancer Center. (n.d.). Paul F. Mansfield, MD.
Retrieved from: https://faculty.mdanderson.org/profiles/paul_mansfield.html
Newhood, T. et. al. (2019, May 26). Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy. Retrived from
Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/30680477
- University of Texas MD Anderson Cancer Center. (n.d.). Clinical Trials: Paul Mansfield. #_ Retrieved from: https://www.mdanderson.org/patients-family/search-results.html?q=Paul%20Mansfield&searchType=clinical%20trials
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Share this article
Last Modified December 17, 2019